Published in Obesity and Diabetes Week, September 22nd, 2003
The new Avandamet dosages of 1 gram metformin combined with 2 or 4 mg rosiglitazone will be available to patients this fall.
"GlaxoSmithKline is pleased with the FDA's approval of the new Avandamet 1 gram tablets as they will offer additional dosing flexibility for the many type 2 diabetes patients who are currently taking a total daily dose of 2 grams of metformin," said David Brand, vice president, metabolic/endocrine marketing, GlaxoSmithKline.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.